Skip to main content
Clinical Trials/NCT00722683
NCT00722683
Withdrawn
Not Applicable

Characterization of Breast Masses Using a New Method of Ultrasound Contrast Agent Imaging in 3D Mapping of Vascular Anomalies

University of Michigan1 site in 1 countryApril 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Michigan
Locations
1
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to determine if breast imaging with ultrasound can be improved by using 1) a ultrasound attachment with two transducers and 2) a contrast agent. These changes might allow smaller blood vessels to be seen than under the way breast ultrasound is usually performed.

Detailed Description

The purpose of this study is to determine if performing ultrasound with an attachment made up of two transducers (rather than just a single transducer) will provide more information about the blood vessels in the breast than the current attachment. The study will also examine the question of whether use of an ultrasound contrast agent will the scanner to see smaller blood vessels than are detected without the agent.

Registry
clinicaltrials.gov
Start Date
April 2001
End Date
December 2010
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jerry LeCarpentier PhD

Principal Investigator

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Female subjects who have breast masses and scheduled for core biopsy.

Exclusion Criteria

  • Pregnant or lactating females.
  • Females who have heart problems or sensitivity to contrast agents.
  • Females who have had previous surgery for breast cancer.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials